Target Healthcare REIT PLC Logo

Target Healthcare REIT PLC

ISIN: GB00BJGTLF51 | Ticker: THRL | LEI: 213800RXPY9WULUSBC04
Sector: Real EstateSub-Industry: Health Care REITs
Country: United Kingdom

About Target Healthcare REIT PLC

Company Description

Target Healthcare REIT PLC is a UK-based real estate investment trust that specializes in investing in healthcare infrastructure. The company's main objective is to deliver long-term value to its shareholders by acquiring and managing high-quality healthcare facilities, such as care homes and retirement living communities.

The company has established a strong reputation in the market for providing exceptional healthcare solutions that meet the needs of an aging population. Target Healthcare REIT also prides itself on the high standards of its facilities, which are maintained to ensure the safety and comfort of its residents.

Target Healthcare REIT's investment approach is guided by a team of experienced professionals who have a deep understanding of the healthcare sector. These experts conduct in-depth research to identify investment opportunities that align with the company's stringent investment criteria.

Year founded

2013

Served area

United Kingdom

Headquarters

Level 13 Broadgate Tower, 20 Primrose Street, EC2A 2EW London – United Kingdom

Financial statements

Download as Excel
Line item in (gbp) 01.07.2020 01.07.2021 01.07.2022
Assets N/A 718,394,000.00 963,658,000.00
Noncurrent Assets N/A 685,987,000.00 923,626,000.00
Investment Property N/A 631,156,000.00 857,691,000.00
Noncurrent Receivables N/A 54,580,000.00 63,651,000.00
Current Assets N/A 32,407,000.00 40,032,000.00
Trade And Other Current Receivables N/A 3,981,000.00 5,549,000.00
Cash and cash equivalents 36,440,000.00 21,106,000.00 34,483,000.00
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 25,087,000.00 40,032,000.00
Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 7,320,000.00 0.00
Equity 494,113,000.00 565,185,000.00 698,767,000.00
Issued Capital N/A 5,115,000.00 6,202,000.00
Retained Earnings N/A 47,564,000.00 75,686,000.00
Share Premium N/A 135,228,000.00 256,633,000.00
Merger Reserve N/A 47,751,000.00 47,751,000.00
Capital Reserve N/A 64,112,000.00 83,750,000.00
Equity Attributable To Owners Of Parent N/A 565,185,000.00 698,767,000.00
Liabilities N/A 153,209,000.00 264,891,000.00
Noncurrent Liabilities N/A 134,744,000.00 238,528,000.00
Noncurrent Payables N/A 6,840,000.00 7,145,000.00
Longterm Borrowings N/A 127,904,000.00 231,383,000.00
Trade And Other Current Payables N/A 18,465,000.00 26,363,000.00
Line item in (gbp) 01.07.2020/
01.07.2021
01.07.2021/
01.07.2022
Revenue 49,980,000.00 63,859,000.00
Revenue From Interest 39,000.00 71,000.00
Other Income 73,000.00 164,000.00
Other Expense By Nature 2,617,000.00 3,163,000.00
Profit Loss Before Tax 43,876,000.00 49,103,000.00
Income Tax Expense Continuing Operations -8,000.00 6,000.00
Profit (loss) 43,884,000.00 49,097,000.00
Line item in (gbp) 01.07.2020 01.07.2021 01.07.2022
Profit (loss) N/A 43,884,000.00 49,097,000.00
Cash Flows From Used In Operations N/A -4,232,000.00 -5,245,000.00
Interest Paid Classified As Operating Activities N/A 4,266,000.00 5,310,000.00
Interest Received Classified As Operating Activities N/A 39,000.00 71,000.00
Income Taxes Paid Refund Classified As Operating Activities N/A 5,000.00 6,000.00
Cash Flows From Used In Operating Activities N/A 24,956,000.00 30,392,000.00
Cash Flows From Used In Investing Activities N/A -43,575,000.00 -202,633,000.00
Proceeds From Issuing Shares N/A 60,000,000.00 125,000,000.00
Proceeds From Borrowings Classified As Financing Activities N/A 152,000,000.00 222,000,000.00
Repayments Of Borrowings Classified As Financing Activities N/A 174,000,000.00 117,250,000.00
Dividends Paid Classified As Financing Activities N/A 31,493,000.00 39,785,000.00
Cash Flows From Used In Financing Activities N/A 3,285,000.00 185,618,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A -15,334,000.00 13,377,000.00
Cash and cash equivalents 36,440,000.00 21,106,000.00 34,483,000.00

Please note that some sums might not add up.

Filings & Publications

2023

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

GB00BJGTLF51

LEI

213800RXPY9WULUSBC04

Sector

Real Estate

Industry Group

Equity Real Estate Investment Trusts (REITs)

Industry

Health Care REITs

Sub-Industry

Health Care REITs

Listed Stock Exchange

London Stock Exchange

Stock Index

FTSE 250

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.